Literature DB >> 8254768

Restriction and enhancement of human immunodeficiency virus type 1 replication by modulation of intracellular deoxynucleoside triphosphate pools.

A Meyerhans1, J P Vartanian, C Hultgren, U Plikat, A Karlsson, L Wang, S Eriksson, S Wain-Hobson.   

Abstract

Human immunodeficiency virus type 1 (HIV-1) replication is shown to be sensitive to the intracellular concentration of deoxynucleoside triphosphate substrates. Addition of thymidine to established cell lines resulted in a dramatic reduction of virus production. The effect could be substantially alleviated by addition of deoxycytidine, which, alone, enhanced viral titers by a factor of 2 to 3. Hydroxyurea treatment abolished HIV-1 replication in peripheral blood mononuclear cells and could be reversed by deoxyadenosine. These data show that HIV-1 replication occurs under suboptimal DNA precursor conditions.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8254768      PMCID: PMC236318     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  44 in total

1.  Analysis of mutagenesis induced by a thermolabile T4 phage deoxycytidylate hydroxymethylase suggests localized deoxyribonucleotide pool imbalance.

Authors:  J P Ji; C K Mathews
Journal:  Mol Gen Genet       Date:  1991-04

2.  Changes in growth properties on passage in tissue culture of viruses derived from infectious molecular clones of HIV-1LAI, HIV-1MAL, and HIV-1ELI.

Authors:  K Peden; M Emerman; L Montagnier
Journal:  Virology       Date:  1991-12       Impact factor: 3.616

3.  Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

Authors:  T Mosmann
Journal:  J Immunol Methods       Date:  1983-12-16       Impact factor: 2.303

4.  Dynamics of pyrimidine deoxynucleoside triphosphate pools in relationship to DNA synthesis in 3T6 mouse fibroblasts.

Authors:  B Nicander; P Reichard
Journal:  Proc Natl Acad Sci U S A       Date:  1983-03       Impact factor: 11.205

5.  Effect of very high-dose thymidine infusions on leukemia and lymphoma patients.

Authors:  M S Blumenreich; T M Woodcock; M Andreeff; W Hiddemann; T C Chou; K Vale; M O'Hehir; B D Clarkson; C W Young
Journal:  Cancer Res       Date:  1984-05       Impact factor: 12.701

6.  Changes in ribo- and deoxyribonucleoside triphosphate pools within the cell cycle of a synchronized mouse fibroblast cell line.

Authors:  P J McCormick; L L Danhauser; Y M Rustum; J S Bertram
Journal:  Biochim Biophys Acta       Date:  1983-03-15

7.  The effects of dNTP pool imbalances on frameshift fidelity during DNA replication.

Authors:  K Bebenek; J D Roberts; T A Kunkel
Journal:  J Biol Chem       Date:  1992-02-25       Impact factor: 5.157

8.  Role of mycoplasma infection in the cytopathic effect induced by human immunodeficiency virus type 1 in infected cell lines.

Authors:  M Lemaître; Y Henin; F Destouesse; C Ferrieux; L Montagnier; A Blanchard
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

9.  Purine and pyrimidine metabolism in human T lymphocytes. Regulation of deoxyribonucleotide metabolism.

Authors:  A Cohen; J Barankiewicz; H M Lederman; E W Gelfand
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

10.  Effect of hydroxyurea and 5-fluorodeoxyuridine on deoxyribonucleoside triphosphate pools early in phytohemagglutinin-stimulated human lymphocytes.

Authors:  G Tyrsted
Journal:  Biochem Pharmacol       Date:  1982-10-01       Impact factor: 5.858

View more
  48 in total

1.  Lentivirus gene transfer in murine hematopoietic progenitor cells is compromised by a delay in proviral integration and results in transduction mosaicism and heterogeneous gene expression in progeny cells.

Authors:  H Mikkola; N B Woods; M Sjögren; H Helgadottir; I Hamaguchi; S E Jacobsen; D Trono; S Karlsson
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

2.  Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors.

Authors:  Grant Trobridge; David W Russell
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

3.  Exploiting drug repositioning for discovery of a novel HIV combination therapy.

Authors:  Christine L Clouser; Steven E Patterson; Louis M Mansky
Journal:  J Virol       Date:  2010-07-07       Impact factor: 5.103

4.  Substitutions in the reverse transcriptase and protease genes of HIV-1 subtype B in untreated individuals and patients treated with antiretroviral drugs.

Authors:  Dan Turner; Bluma Brenner; Daniela Mosis; Chen Liang; Mark A Wainberg
Journal:  MedGenMed       Date:  2005-03-24

5.  L1 retrotransposition in nondividing and primary human somatic cells.

Authors:  Shuji Kubo; Maria Del Carmen Seleme; Harris S Soifer; José Luis Garcia Perez; John V Moran; Haig H Kazazian; Noriyuki Kasahara
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-12       Impact factor: 11.205

Review 6.  HIV-1 transcription and latency: an update.

Authors:  Carine Van Lint; Sophie Bouchat; Alessandro Marcello
Journal:  Retrovirology       Date:  2013-06-26       Impact factor: 4.602

Review 7.  Understanding HIV-1 latency provides clues for the eradication of long-term reservoirs.

Authors:  Mayte Coiras; María Rosa López-Huertas; Mayte Pérez-Olmeda; José Alcamí
Journal:  Nat Rev Microbiol       Date:  2009-11       Impact factor: 60.633

8.  Hypermutagenesis of RNA using human immunodeficiency virus type 1 reverse transcriptase and biased dNTP concentrations.

Authors:  M A Martinez; J P Vartanian; S Wain-Hobson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-06       Impact factor: 11.205

9.  Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection.

Authors:  Theodore C Pierson; Yan Zhou; Tara L Kieffer; Christian T Ruff; Christopher Buck; Robert F Siliciano
Journal:  J Virol       Date:  2002-09       Impact factor: 5.103

10.  Inhibitory effect of nitric oxide on the replication of a murine retrovirus in vitro and in vivo.

Authors:  K Akarid; M Sinet; B Desforges; M A Gougerot-Pocidalo
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.